What Are Risk Factors for GBS? According to the CDC, GBS is rare and affects only about one in 100,000 people. In the U.S., around 3,000 to 6,000 people develop GBS each year.

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus (RSV) vaccine. Two people in … ...

Background Guillain-Barre syndrome (GBS) is characterized by acute onset and progressive course, and is usually associated with a good prognosis. However, there are forms of poor prognosis ...

Guillain-Barre syndrome is a rare but serious condition which needs urgent treatment in hospital to prevent it progressing.

A new study indicates that COVID-19 is associated with an elevated risk of a rare disorder, Guillain-Barré syndrome, within six weeks after infection with the virus.

People with lymphoma and blood cancers, as well as those who have lung, prostate or breast cancer, may be at higher risk for having new onset Guillain-Barré syndrome, a study published by the ...

The Food and Drug Administration has flagged Guillain-Barre syndrome, a rare neurological condition, as a potential risk for Pfizer’s respiratory syncytial virus vaccine. Two people in their 60s ...

Source Reference: Goud R, et al "Risk of Guillain-Barré syndrome following recombinant zoster vaccine in Medicare beneficiaries" JAMA Intern Med 2021; DOI: 10.1001/jamainternmed.2021.6227.

A haywire immune system, attacking healthy nerves, causes the disorder. U.S. health authorities added a warning to the label of J&J’s Covid-19 vaccine after finding 100 reports.

Guillain-Barre Syndrome (GBS) cases are on the rise in Pune and the nearby areas. According to the latest report, a man suspected to have contracted the condition has died in Maharashtra's Solapur ...

Peru’s health ministry said on Thursday that Corinthians are not at risk of contracting Guillain-Barre syndrome when they visit the country next week after the coach of the Brazilian team voiced ...

Guillain-Barré Syndrome: Natural History and Prognostic Factors A Retrospective Review of 106 Cases Inés González-Suárez; Irene Sanz-Gallego; Francisco Javier Rodríguez de Rivera; Javier Arpa ...